Ads
related to: acute myeloid leukemia treatment- Efficacy Data
Studied against the best available
therapies for myelofibrosis
- Mechanism of Action
Learn about the MOA
of a new treatment option
- Efficacy Data
Search results
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug...
WPRI Providence· 6 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that its ...
Bob Asmussen | Leukemia survivor Roux doing his part to fight the disease
The News-Gazette, Champaign-Urbana, Ill. via Yahoo News· 2 days agoMay 28—In 2003 at age 9, Champaign's Alex Roux had a bruise on his arm that wouldn't go away. There were no other symptoms. "I wasn't fatigued or tired or anything," Roux said. He was tested ...
Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
WROC Rochester· 6 days agoOral presentation of final five-year results from the registrational Phase 2 trial in R/R mIDH1 AML patients reinforces REZLIDHIA® (olutasidenib) efficacy in heavily pretreated patients, including ...
All over the body: Here are the key clinical trials from Bay Area firms - San Francisco Business...
The Business Journals· 5 days agoSince the turn of the millennium, Bay Area organizations and researchers have launched more than 300...
Texans' John Metchie III wins George Halas award | SportsTalk 790
iHeartRadio· 2 days agoIII was recognized for his perseverance Tuesday as he won the annual George Halas award from the...
The 3 Best Machine Learning Stocks to Quadruple Your Money by 2035
InvestorPlace via Yahoo Finance· 7 days agoOne of the hottest investment trends to jump on at the moment is machine learning stocks to buy....
NCI-MATCH Precision Medicine Clinical Trial
National Cancer Institute· 7 days agoNCI-MATCH, also known as MATCH, is a precision medicine cancer treatment clinical trial that sought to find out if treating cancer based on specific...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 7 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Deciphering Unexpected Vascular Locations of Scedosporium spp. and Lomentospora prolificans Fungal...
Centers for Disease Control and Prevention· 6 days agoWe describe an underrecognized Scedosporium spp. and Lomentospora prolificans vascular tropism requiring specific management of which clinicians should be aware.
Swiss National Bank Trims Stake in Kura Oncology, Inc. (NASDAQ:KURA)
ETF DAILY NEWS· 2 days agoSwiss National Bank trimmed its stake in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 16.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission ...
Ad
related to: acute myeloid leukemia treatment